This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MARTHA RUBIN FOLK, M.D.

AMA Arch Ophthalmol. 1955;53(1):93.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MANY DRUGS have been used in an attempt to abort the vascular complications of diabetes mellitus. To date none has proved effective. Recently the liver has been implicated as possibly playing a role in these vascular complications. A tendency toward fatty infiltration of the liver has been noted in diabetes and arteriosclerosis. This fatty infiltration is believed to impair liver function and thereby predispose, in some as yet unknown manner, to increased vascular disease. By reducing fatty infiltration by the use of lipotropic substances, and thereby improving liver function, it is hoped that the vascular disease will be arrested. The lipoliquid used in this study contains choline, the most effective lipotropic agent known, inositol, and vitamin B₁₂, believed to be catalysts in the formation of the mobile cholinebased phospholipids.

It is the purpose of this report to note the effect of Lipoliquid used in the treatment of 50 consecutive . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

From the Department of Ophthalmology of the Mount Sinai Hospital and the Chicago Medical School.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?